Henry Hongrong Cai* and Ayesha Pandit

Premier Research, 3800 Paramount Parkway, Morrisville, NC, USA

*Corresponding Author: Henry Hongrong Cai, Premier Research, 3800 Paramount Parkway, Morrisville, NC, USA.

Received: October 19, 2022; Published: October 27, 2022

Abstract

AMD: Age-Related Macular Degeneration; ANGPTL3: Angiopoietin-like 3; ARIA: Amyloid Related Imaging Abnormalities; AS: Ankylosing Spondylitis; ATE f: Arterial Thromboembolic Even; CD: Crohn’s Disease; CR: Cutaneous Reactions; DAE: Dermatologic Adverse Reactions; DLBCL: Diffuse Large B-cell Lymphoma; dMMR EC: Mismatch Repair Deficient Endometrial Cancer; EE: Effusion and Edema; EFT: Embryo-Fetal Toxicity; EGFR: Epidermal Growth Factor Receptor; ERD: Endophthalmitis and Retinal Detachment; HoFH: Homozygous Familial Hypercholesterolemia (HoFH); HR: Hypersensitivity Reactions; (I)INFR: Type I Interferon Receptor; IIOP: Increases in Intraocular Pressure; ILD: Interstitial Lung Disease; ILI: Influenza-like Illness; IMAE: Immune-mediated Adverse Reactions; IRR: Infusion-related Reactions; JIA: Juvenile Idiopathic Arthritis; LBCL: Large B-cell Lymphoma; LDL-C: Low-Density Lipoprotein-Cholesterol; mCNV: Myopic Choroidal Neovascularization; MET: Receptor MET Also Known as Hepatocyte Growth Factor Receptor; MS: Myelosuppression; NSCLC: Non-Small Cell Lung Cancer; OT: Ocular Toxicity; PD-1: Programmed Death Receptor-1; PN: Peripheral Neuropath; Ps: Plaque Psoriasis; PsA: Psoriatic Arthritis; RA: Rheumatoid Arthritis; RVO: Retinal Vein Occlusion; SHR: Serious Hypersensitivity Reactions; SI: Serious Infections; SLE: Systemic Lupus Erythematosus; TNF: Tumor Necrosis Factor; TSLP: Thymic Stromal Lymphopoietin; URTI: Upper Respiratory Tract Infections; UC: Ulcerative Colitis; VEGF: Vascular Endothelial Growth Factor

References

1. https://asclepiusopen.com/clinical-research-in-immunology/volume-4-issue-1/1.pdf
2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761181s000lbl.pdf
3. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761174s000lbl.pdf
4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761196s000lbl.pdf
5. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761210s001lbl.pdf
6. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761178s003lbl.pdf
7. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761123s000lbl.pdf
8. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761223s000lbl.pdf
9. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761202s000lbl.pdf
10. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761208Orig1s000lbledt.pdf
11. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761197s000lbl.pdf
12. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761216s000lbl.pdf
13. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761224s000lbl.pdf
14. Label for ADBRY not available yet.

Citation

Citation: Henry Hongrong Cai and Ayesha Pandit. “Therapeutic Monoclonal Antibodies Approved by FDA in 2021". Acta Scientific Microbiology 5.11 (2022): 81-83.

Copyright

Copyright: © 2022 Henry Hongrong Cai and Ayesha Pandit. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.